- Home
- DGLY vs APM Comparison
DGLY vs APM Comparison
Compare DGLY & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGLY
- APM
- Stock Information
- Founded
- DGLY 2004
- APM 2010
- Country
- DGLY United States
- APM United Kingdom
- Employees
- DGLY N/A
- APM N/A
- Industry
- DGLY Radio And Television Broadcasting And Communications Equipment
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- DGLY Technology
- APM Health Care
- Exchange
- DGLY Nasdaq
- APM Nasdaq
- Market Cap
- DGLY 3.5M
- APM 4.0M
- IPO Year
- DGLY N/A
- APM 2018
- Fundamental
- Price
- DGLY $0.56
- APM $0.76
- Analyst Decision
- DGLY
- APM
- Analyst Count
- DGLY 0
- APM 0
- Target Price
- DGLY N/A
- APM N/A
- AVG Volume (30 Days)
- DGLY 186.6K
- APM 55.6K
- Earning Date
- DGLY 12-27-2024
- APM 12-27-2024
- Dividend Yield
- DGLY N/A
- APM N/A
- EPS Growth
- DGLY N/A
- APM N/A
- EPS
- DGLY N/A
- APM N/A
- Revenue
- DGLY $23,417,110.00
- APM $431,378.00
- Revenue This Year
- DGLY $22.14
- APM $157,729.10
- Revenue Next Year
- DGLY N/A
- APM N/A
- P/E Ratio
- DGLY N/A
- APM N/A
- Revenue Growth
- DGLY N/A
- APM N/A
- 52 Week Low
- DGLY $0.51
- APM $0.46
- 52 Week High
- DGLY $3.29
- APM $17.49
- Technical
- Relative Strength Index (RSI)
- DGLY 33.18
- APM 40.52
- Support Level
- DGLY $0.51
- APM $0.73
- Resistance Level
- DGLY $0.78
- APM $0.78
- Average True Range (ATR)
- DGLY 0.10
- APM 0.09
- MACD
- DGLY -0.01
- APM 0.04
- Stochastic Oscillator
- DGLY 14.17
- APM 59.96
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.